Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 361 | ERAS | ERASCA INC | Healthcare | 46,231.0 | $172K | 0.01% | -3K | -7.0% | $3.72 | +202.2% |
| 362 | PODD | INSULET CORP | Healthcare | 600.0 | $171K | 0.01% | NEW | — | $284.24 | -45.5% |
| 363 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 18,874.0 | $170K | 0.01% | -20K | -51.4% | $8.99 | +40.2% |
| 364 | LI | LI AUTO INC - ADR | Consumer Cyclical | 10,000.0 | $169K | 0.01% | -20K | -66.7% | $16.93 | -6.1% |
| 365 | PVLA | PALVELLA THERAPEUTICS INC | Healthcare | 1,600.0 | $167K | 0.01% | NEW | — | $104.67 | +8.9% |
| 366 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 48,777.0 | $167K | 0.01% | -4K | -6.9% | $3.42 | +52.0% |
| 367 | DEO | DIAGEO PLC-SPONSORED ADR | Consumer Defensive | 1,884.0 | $163K | 0.01% | -2K | -54.2% | $86.27 | -0.2% |
| 368 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 5,000.0 | $157K | 0.01% | -3K | -37.5% | $31.46 | -7.8% |
| 369 | DAWN | DAY ONE BIOPHARMACEUTICALS I | Healthcare | 16,731.0 | $156K | 0.01% | -1K | -6.8% | $9.32 | +131.0% |
| 370 | ALMS | ALUMIS INC | Healthcare | 15,840.0 | $155K | 0.01% | -1K | -6.7% | $9.76 | +125.6% |
| 371 | TBPH | THERAVANCE BIOPHARMA INC | Healthcare | 8,257.0 | $154K | 0.01% | -571.0 | -6.5% | $18.71 | -12.5% |
| 372 | — | RAPT THERAPEUTICS INC | — | 4,515.0 | $153K | 0.01% | NEW | — | $33.87 | — |
| 373 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 31,339.0 | $151K | 0.01% | -2K | -6.7% | $4.81 | -9.6% |
| 374 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 8,927.0 | $150K | 0.01% | NEW | — | $16.83 | +28.8% |
| 375 | CRMD | CORMEDIX INC | Healthcare | 12,839.0 | $149K | 0.01% | -246.0 | -1.9% | $11.63 | -31.4% |
| 376 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 9,671.0 | $149K | 0.01% | -712.0 | -6.9% | $15.40 | +169.7% |
| 377 | GOSS | GOSSAMER BIO INC | Healthcare | 47,716.0 | $148K | 0.01% | NEW | — | $3.10 | -93.2% |
| 378 | KURA | KURA ONCOLOGY INC | Healthcare | 14,179.0 | $147K | 0.01% | -1K | -6.8% | $10.39 | +8.3% |
| 379 | — | MESOBLAST LTD- SPON ADR | — | 7,992.0 | $144K | 0.01% | -284.0 | -3.4% | $18.04 | — |
| 380 | ESPR | ESPERION THERAPEUTICS INC | Healthcare | 38,955.0 | $144K | 0.01% | +4K | +10.2% | $3.70 | -15.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%